Yi Larson
2021 - LianBio
In 2021, Yi Larson earned a total compensation of $7.8M as Chief Financial Officer at LianBio.
Compensation breakdown
| Non-Equity Incentive Plan | $214,443 |
|---|---|
| Option Awards | $7,027,427 |
| Salary | $333,333 |
| Stock Awards | $218,113 |
| Total | $7,793,316 |
Larson received $7M in option awards, accounting for 90% of the total pay in 2021.
Larson also received $214.4K in non-equity incentive plan, $333.3K in salary and $218.1K in stock awards.
Rankings
In 2021, Yi Larson's compensation ranked 1,498th out of 12,415 executives tracked by ExecPay. In other words, Larson earned more than 87.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,498 out of 12,415 | 88th |
Division Manufacturing | 543 out of 5,508 | 90th |
Major group Chemicals And Allied Products | 205 out of 2,378 | 91st |
Industry group Drugs | 170 out of 2,099 | 92nd |
Industry Pharmaceutical Preparations | 116 out of 1,549 | 93rd |
Source: SEC filing on April 27, 2022.
Larson's colleagues
We found three more compensation records of executives who worked with Yi Larson at LianBio in 2021.